James Rusche, PhD, Sr. Vice President, Research and Development, Repligen Corporation, discusses the work his company has done to identify development candidate for Friedreich's Ataxia.
Popular Posts
-
Cleft lip and cleft palate, which can also occur together as cleft lip and palate are variations of a type of clefting congenital deformity ... -
Irritable bowel syndrome (IBS) is a functional bowel disorder characterized by mild to severe abdominal pain, discomfort, bloating and alter...
-
Cell membrane (also called the plasma membrane, plasmalemma, or "phospholipid bilayer") is a selectively permeable lipid bilayer f...
-
The olfactory system is the sensory system used for olfaction. Most mammals and reptiles have two distinct parts to their olfactory system: ...
-
DNA extraction is a routine procedure to collect DNA for subsequent molecular or forensic analysis. There are three basic steps in a DNA ext...
-
The western blot (alternately, immunoblot) is a method of detecting specific proteins in a given sample of tissue homogenate or extract. It ... -
AutoDock is a suite of automated docking tools. It is designed to predict how small molecules, such as substrates or drug candidates, bind t... -
Ron Levy, MD, professor of Medicine at Stanford, recounts his experiences moving his discovery from the lab to the clinical setting and disc...
No comments:
Write comments